MedPath

Automated Text Message Reminders to Promote Hearing Aid Adoption

Not Applicable
Not yet recruiting
Conditions
Hearing Loss
Registration Number
NCT07170423
Lead Sponsor
Stanford University
Brief Summary

Many individuals with hearing loss do not receive adequate hearing healthcare. Only about 30 percent of people that are found to have hearing loss during a hearing test go on to use hearing aids. The investigators propose to test the use of text message reminders to educate patients with hearing loss, and to encourage them to get hearing aids. The study objective is to examine whether automated text-messaging reminders increase the use of hearing aids among patients with hearing loss, who are hearing aid candidates.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
190
Inclusion Criteria
  • English-speaking adult patients who have been recommended for hearing aids.
Exclusion Criteria
  • Patients will be excluded if they use hearing aids or cochlear implants.
  • Patients without a valid cellphone number will be excluded.
  • Patients with dementia will also be excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Likelihood of obtaining hearing aidsThis outcome data will be collected 3, 6, 9, and 12 months after enrollment.

Participants will be queried on whether they have obtained hearing aids since enrollment in the study. Participants who have not obtained hearing aids, will be asked to rate the likelihood that they would obtain hearing aids. Likelihood will be assessed on an 11-point visual analogue scale (VAS). Score range: 0 to 10 (0 = not likely, 10 = very likely). Participants who have already obtained hearing aids will be assigned a score of 10.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

πŸ‡ΊπŸ‡Έ

Stanford, California, United States

Stanford University
πŸ‡ΊπŸ‡ΈStanford, California, United States
Principal Investigator
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.